The task was straightforward, though extremely difficult: Get the FDA to consider a different efficacy endpoint for approval.
Discover our resources
Resource types
Topics
-
Download Case Study The task was straightforward, though extremely difficult: Get the FDA to consider a different efficacy endpoint for approval.
-
Download Case Study Characterization of Specific EGFR Mutations in CTCs Isolated by ApoStream® in NSCLC Patients
Characterization of Specific EGFR Mutations in CTCs Isolated by ApoStream® in NSCLC Patients
-
Download Case Study Navigating logistical complexity in cell therapy trials
Navigating logistical complexity in cell therapy trials
-
Download Case Study A Study of the eIF4E Pathway in CTCs Isolated from NSCLC and Prostate Cancer Patients Using ApoStream®
A Study of the eIF4E Pathway in CTCs Isolated from NSCLC and Prostate Cancer Patients Using ApoStream®
-
Download Case Study Harnessing Flow Cytometry Data to Keep a Phase 1 Trial on Track
Harnessing Flow Cytometry Data to Keep a Phase 1 Trial on Track
-
Download Case Study Experience With Multiple Myeloma Rescues a Global Phase 3 Trial
Experience With Multiple Myeloma Rescues a Global Phase 3 Trial
-
Download Case Study When the FDA Has Questions: Finding Answers in the Data
When the FDA Has Questions: Finding Answers in the Data
-
Download Case Study A “Basket” Trial and an Accelerated Pathway to Proof-of-Concept
A “Basket” Trial and an Accelerated Pathway to Proof-of-Concept
